Location: New York, NY
CIK: 0001746382 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 6, 2021
Total Value: $360M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CURIS INC | 772,009 | $8.739M | 2.4% | $8.19 | — | COM NEW | 231269200 |
| — | VERRICA PHARMACEUTICALS INC | 562,954 | $8.529M | 2.4% | $14.45 | — | COM | 92511W108 |
| — | PROGENITY INC | 1,748,252 | $8.322M | 2.3% | $4.76 | — | COM | 74319F107 |
| — | CHARDAN HEALTHCR ACQSTN 2 CO | 753,374 | $7.571M | 2.1% | $10.13 | — | COM | 15957T107 |
| — | ESSA PHARMA INC | 230,063 | $6.683M | 1.9% | $16.02 | — | COM NEW | 29668H708 |
| ALDX | ALDEYRA THERAPEUTICS INC | 548,225 | $6.513M | 1.8% | $11.52 | 0.0% | COM | 01438T106 |
| — | VERASTEM INC | 2,573,222 | $6.356M | 1.8% | $2.13 | — | COM | 92337C104 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 238,354 | $6.173M | 1.7% | $22.36 | +13.2% | COM | 74366E102 |
| — | BELLUS HEALTH INC NEW | 1,573,389 | $6.042M | 1.7% | $3.06 | — | COM NEW | 07987C204 |
| LNTH | LANTHEUS HLDGS INC | 275,066 | $5.878M | 1.6% | $13.32 | +36.2% | COM | 516544103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 253,448 | $5.667M | 1.6% | $20.74 | +8.9% | COM | 87164F105 |
| — | IVERIC BIO INC | 902,633 | $5.578M | 1.5% | $6.91 | — | COM | 46583P102 |
| CDNA | CAREDX INC | 81,284 | $5.535M | 1.5% | $77.64 | 0.0% | COM | 14167L103 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 361,930 | $5.53M | 1.5% | $13.93 | +11.3% | COM | 22663K107 |
| PODD | INSULET CORP | 21,000 | $5.479M | 1.5% | $252.60 | +6.0% | COM | 45784P101 |
| — | SIENTRA INC | 739,045 | $5.388M | 1.5% | $3.89 | — | COM | 82621J105 |
| OCUL | OCULAR THERAPEUTIX INC | 326,174 | $5.313M | 1.5% | $15.16 | +27.0% | COM | 67576A100 |
| AUPH | AURINIA PHARMACEUTICALS INC | 408,908 | $5.31M | 1.5% | $14.54 | -0.2% | COM | 05156V102 |
| — | NEVRO CORP | 37,900 | $5.287M | 1.5% | $139.50 | — | COM | 64157F103 |
| TVTX | TRAVERE THERAPEUTICS INC | 210,484 | $5.256M | 1.5% | $26.07 | +6.0% | COM | 89422G107 |
| MYGN | MYRIAD GENETICS INC | 171,785 | $5.231M | 1.5% | $16.15 | +75.7% | COM | 62855J104 |
| — | SUTRO BIOPHARMA INC | 226,719 | $5.16M | 1.4% | $21.71 | — | COM | 869367102 |
| — | NOCTURNE ACQUISITION CORP | 500,000 | $5M | 1.4% | $10.00 | — | UNIT 02/25/2026 | G6580S122 |
| — | CELSION CORP | 3,496,154 | $4.825M | 1.3% | $1.38 | — | COM PAR NEW | 15117N503 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 223,000 | $4.743M | 1.3% | $29.00 | 0.0% | COM | 76243J105 |
| — | TCR2 THERAPEUTICS INC | 209,130 | $4.618M | 1.3% | $25.21 | — | COM | 87808K106 |
| — | FORTE BIOSCIENCES INC | 134,542 | $4.611M | 1.3% | $34.27 | — | COM | 34962G109 |
| MREO | MEREO BIOPHARMA GROUP PLC | 1,250,000 | $4.213M | 1.2% | $3.37 | — | ADS | 589492107 |
| — | HARPOON THERAPEUTICS INC | 199,607 | $4.176M | 1.2% | $18.72 | — | COM | 41358P106 |
| — | EUCRATES BIOMEDICAL ACQU COR | 400,000 | $4.005M | 1.1% | $10.66 | — | UNIT 10/23/2027 | G3141W114 |
| — | AVADEL PHARMACEUTICALS PLC | 440,589 | $3.983M | 1.1% | $6.68 | — | SPONSORED ADR | 05337M104 |
| — | ARYA SCIENCES ACQUISITION CO | 286,383 | $3.946M | 1.1% | $10.85 | — | COM CL A | G3166W106 |
| RNAM | AVIDITY BIOSCIENCES INC | 178,600 | $3.895M | 1.1% | $24.48 | 0.0% | COM | 05370A108 |
| IMTX | IMMATICS N.V | 344,558 | $3.862M | 1.1% | $10.55 | +7.5% | SHS | N44445109 |
| INSM | INSMED INC | 110,254 | $3.755M | 1.0% | $36.53 | +4.6% | COM PAR $.01 | 457669307 |
| CTMX | CYTOMX THERAPEUTICS INC | 483,041 | $3.734M | 1.0% | $7.48 | +5.8% | COM | 23284F105 |
| — | CONSTELLATION PHARMCETICLS I | 158,733 | $3.713M | 1.0% | $27.97 | — | COM | 210373106 |
| IMVT | IMMUNOVANT INC | 229,622 | $3.683M | 1.0% | $33.08 | -20.3% | COM | 45258J102 |
| — | TFF PHARMACEUTICALS INC | 269,691 | $3.66M | 1.0% | $13.57 | — | COM | 87241J104 |
| — | ALPHA HEALTHCARE ACQUISTN CO | 275,000 | $3.436M | 1.0% | $10.57 | — | UNIT 09/21/2027 | 020751202 |
| — | NEWAGE INC | 1,198,150 | $3.427M | 1.0% | $2.86 | — | COM | 650194103 |
| GKOS | GLAUKOS CORP | 40,800 | $3.424M | 1.0% | $87.94 | 0.0% | COM | 377322102 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 113,962 | $3.297M | 0.9% | $27.51 | +13.5% | COM | 03969K108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 128,130 | $3.292M | 0.9% | $26.28 | 0.0% | COM | 483497103 |
| — | CHINOOK THERAPEUTICS INC | 205,799 | $3.198M | 0.9% | $15.86 | — | COM | 16961L106 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 972,327 | $3.141M | 0.9% | $3.34 | 0.0% | COM | 45665G303 |
| ILMN | ILLUMINA INC | 8,000 | $3.072M | 0.9% | $318.77 | +27.9% | COM | 452327109 |
| IFRX | INFLARX NV | 774,600 | $3.021M | 0.8% | $5.12 | 0.0% | COM | N44821101 |
| GMED | GLOBUS MED INC | 48,862 | $3.013M | 0.8% | $59.56 | +6.3% | CL A | 379577208 |
| — | INTRA CELLULAR THERAPIES INC | 88,326 | $2.997M | 0.8% | $31.80 | — | COM | 46116X101 |
| — | INTERSECT ENT INC | 141,856 | $2.962M | 0.8% | $22.30 | — | COM | 46071F103 |
| — | MORPHIC HLDG INC | 46,541 | $2.945M | 0.8% | $63.28 | — | COM | 61775R105 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 289,316 | $2.939M | 0.8% | $11.25 | 0.0% | COM NEW | 30233G209 |
| — | NUVASIVE INC | 43,133 | $2.828M | 0.8% | $65.56 | — | COM | 670704105 |
| — | GEMINI THERAPEUTICS INC | 203,995 | $2.764M | 0.8% | $13.55 | — | COM | 36870G105 |
| — | PHASEBIO PHARMACEUTICALS INC | 775,000 | $2.682M | 0.7% | $3.46 | — | COM | 717224109 |
| DYN | DYNE THERAPEUTICS INC | 166,636 | $2.588M | 0.7% | $19.35 | 0.0% | COM | 26818M108 |
| — | CONFORMIS INC | 2,608,875 | $2.583M | 0.7% | $0.99 | — | COM | 20717E101 |
| MLTX | HELIX ACQUISITION CORP | 250,000 | $2.55M | 0.7% | $11.37 | — | COM CL A | G4444C102 |
| PROF | PROFOUND MED CORP | 126,427 | $2.546M | 0.7% | $23.98 | 0.0% | COM NEW | 74319B502 |
| — | TURMERIC ACQUISITION CORP | 254,000 | $2.54M | 0.7% | $10.27 | — | UNIT 10/08/2025 | G9127T116 |
| — | LIFESCI ACQUISITION II CORP | 250,000 | $2.535M | 0.7% | $10.67 | — | COM | 53229E103 |
| — | CONSONANCE HFW ACQUISITION C | 250,000 | $2.44M | 0.7% | $10.47 | — | UNIT 99/99/9999 | G2445M129 |
| — | SARISSA CAPITAL ACQUISITN CO | 225,000 | $2.437M | 0.7% | $10.65 | — | UNIT 10/23/2027 | G7823W128 |
| CYTK | CYTOKINETICS INC | 103,262 | $2.402M | 0.7% | $21.35 | 0.0% | COM NEW | 23282W605 |
| IRD | OCUPHIRE PHARMA INC # | 397,036 | $2.306M | 0.6% | $6.91 | +34.5% | COM | 67577R102 |
| WVE | WAVE LIFE SCIENCES LTD | 398,997 | $2.238M | 0.6% | $9.61 | 0.0% | SHS | Y95308105 |
| — | MEI PHARMA INC | 638,083 | $2.189M | 0.6% | $3.43 | — | COM NEW | 55279B202 |
| VREX | VAREX IMAGING CORP | 105,727 | $2.166M | 0.6% | $21.42 | 0.0% | COM | 92214X106 |
| — | ADAMAS PHARMACEUTICALS INC | 450,000 | $2.16M | 0.6% | $4.80 | — | COM | 00548A106 |
| — | SERES THERAPEUTICS INC | 104,626 | $2.154M | 0.6% | $20.59 | — | COM | 81750R102 |
| — | AEGLEA BIOTHERAPEUTICS INC | 267,753 | $2.121M | 0.6% | $7.87 | — | COM | 00773J103 |
| — | PYXIS TANKERS INC | 2,035,793 | $2.097M | 0.6% | $1.03 | — | COM | Y71726106 |
| — | CALITHERA BIOSCIENCES INC | 853,902 | $2.066M | 0.6% | $2.42 | — | COM | 13089P101 |
| HYPR | HEALTHCOR CATALIO ACQU CORP | 200,000 | $2M | 0.6% | $10.00 | — | CL A SHS | G44125105 |
| CHRS | COHERUS BIOSCIENCES INC | 136,623 | $1.996M | 0.6% | $17.80 | -4.6% | COM | 19249H103 |
| — | FS DEVELOPMENT CORP II | 200,000 | $1.992M | 0.6% | $9.96 | — | COM CL A | 30318F100 |
| — | JIYA ACQUISITION CORP | 200,000 | $1.968M | 0.5% | $10.30 | — | COM CL A | 47760M102 |
| — | YUMANITY THERAPEUTICS INC | 108,695 | $1.967M | 0.5% | $18.10 | — | COM | 98872L102 |
| — | MAGENTA THERAPEUTICS INC | 164,381 | $1.946M | 0.5% | $11.84 | — | COM | 55910K108 |
| — | LANDCADIA HOLDINGS III INC | 192,314 | $1.925M | 0.5% | $10.01 | — | COM CL A | 51476H100 |
| HAE | HAEMONETICS CORP MASS | 17,044 | $1.892M | 0.5% | $107.66 | +14.9% | COM | 405024100 |
| TMPOQ | ACE CONVERGENCE ACQU CORP | 189,000 | $1.884M | 0.5% | $9.97 | — | CL A | G0083D120 |
| CSTL | CASTLE BIOSCIENCES INC | 27,365 | $1.873M | 0.5% | $54.21 | +38.7% | COM | 14843C105 |
| — | ADICET BIO INC | 142,289 | $1.861M | 0.5% | $13.08 | — | COM | 007002108 |
| — | SALARIUS PHARMACEUTICALS INC | 1,250,110 | $1.85M | 0.5% | $1.48 | — | COM NEW | 79400X107 |
| — | EIGER BIOPHARMACEUTICALS INC | 197,500 | $1.748M | 0.5% | $12.29 | — | COM | 28249U105 |
| — | CTI BIOPHARMA CORP | 588,992 | $1.714M | 0.5% | $3.22 | — | COM | 12648L601 |
| STIM | NEURONETICS INC | 137,500 | $1.701M | 0.5% | $15.33 | 0.0% | COM | 64131A105 |
| BWAY | BRAINSWAY LTD | 179,506 | $1.621M | 0.4% | $9.03 | — | SPONSORED ADS | 10501L106 |
| XGN | EXAGEN INC | 86,475 | $1.513M | 0.4% | $17.82 | 0.0% | COM | 30068X103 |
| — | CM LIFE SCIENCES INC | 100,000 | $1.489M | 0.4% | $14.89 | — | COM CL A | 18978W109 |
| — | ONCTERNAL THERAPEUTICS INC | 176,287 | $1.467M | 0.4% | $4.90 | — | COM | 68236P107 |
| — | VALLON PHARMACEUTICALS INC | 300,000 | $1.392M | 0.4% | $4.64 | — | COM | 92023M101 |
| LRMR | LARIMAR THERAPEUTICS INC | 93,261 | $1.363M | 0.4% | $20.04 | -9.3% | COM | 517125100 |
| — | BCTG ACQUISITION CORP | 120,000 | $1.334M | 0.4% | $11.44 | — | COM | 05492W103 |
| — | TAILWIND ACQUISITION CORP | 128,414 | $1.274M | 0.4% | $9.92 | — | COM CL A | 87403Q102 |
| VRAYQ | VIEWRAY INC | 289,114 | $1.258M | 0.3% | $4.86 | 0.0% | COM | 92672L107 |
| — | GIGCAPITAL4 INC | 125,000 | $1.234M | 0.3% | $9.87 | — | UNIT 99/99/9999 | 37518G200 |
| — | BCLS ACQUISITION CORP | 100,000 | $1.057M | 0.3% | $11.14 | — | COM CL A | G0904B105 |
| — | FAT BRANDS INC | 300,000 | $1.056M | 0.3% | $2.70 | — | *W EXP 06/30/202 | 30258N121 |
| — | ROTH CH ACQUISITION II CO | 100,000 | $1.054M | 0.3% | $10.40 | — | UNIT 12/11/2025 | 778673202 |
| — | ARYA SCIENCES ACQU CORP IV | 100,000 | $1.047M | 0.3% | $10.47 | — | CL A | G31659108 |
| — | AJAX I | 100,000 | $1.026M | 0.3% | $10.26 | — | COM | G0190X100 |
| — | QELL ACQUISITION CORP | 100,000 | $1.018M | 0.3% | $10.18 | — | CL A | G7307X105 |
| — | SUPERNOVA PARTNERS ACQUISITI | 100,000 | $1.011M | 0.3% | $10.11 | — | COM CL A | 86846V108 |
| — | MOTIVE CAPITAL CORP | 102,099 | $1.001M | 0.3% | $9.80 | — | SHS CL A | G6293A103 |
| — | CITIC CAPITAL ACQUISITION CO | 100,000 | $1M | 0.3% | $10.00 | — | COM CL A | G21513109 |
| — | FIRSTMARK HORIZON ACQUISITIO | 100,000 | $1M | 0.3% | $10.00 | — | CL A COM | 33765Y101 |
| — | OMEGA ALPHA SPAC | 100,000 | $990K | 0.3% | $9.90 | — | CL A | G6749V107 |
| — | SYROS PHARMACEUTICALS INC | 126,702 | $948K | 0.3% | $7.48 | — | COM | 87184Q107 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 45,013 | $927K | 0.3% | $18.00 | +27.6% | COM NEW | 15117B202 |
| — | VINCERX PHARMA INC | 215,250 | $870K | 0.2% | $3.30 | — | *W EXP 12/24/202 | 92731L114 |
| — | CHARDAN HEALTHCR ACQSTN 2 CO | 731,561 | $688K | 0.2% | $0.97 | — | *W EXP 03/05/202 | 15957T115 |
| — | BRIACELL THERAPEUTICS CORP | 500,000 | $535K | 0.1% | $1.07 | — | *W EXP 02/24/202 | 10778Y112 |
| — | CATALYST BIOSCIENCES INC | 89,930 | $453K | 0.1% | $6.31 | — | COM NEW | 14888D208 |
| — | VERB TECHNOLOGY CO INC | 281,173 | $394K | 0.1% | $1.40 | — | COM | 92337U104 |
| — | CM LIFE SCIENCES INC | 66,666 | $345K | 0.1% | $5.18 | — | *W EXP 09/04/202 | 18978W117 |
| — | IMMATICS N.V | 97,467 | $288K | 0.1% | $2.88 | — | *W EXP 07/01/202 | N44445117 |
| — | GENPREX INC | 60,909 | $263K | 0.1% | $4.15 | — | COM | 372446104 |
| — | EVAXION BIOTECH A S | 24,725 | $146K | 0.0% | $5.90 | — | ADS | 29970R105 |
| — | AMPLITUDE HLTHCRE AQUSTIN CO | 162,500 | $133K | 0.0% | $1.45 | — | *W EXP 12/01/202 | 03212A113 |
| — | HEALTH SCIENCES ACQ CORP 2 | 10,000 | $112K | 0.0% | $12.80 | — | ORD SHS | G4411D109 |
| SHPSQ | GALILEO ACQUISITION CORP | 200,000 | $110K | 0.0% | $0.84 | — | *W EXP 10/31/202 | G3770A110 |